Mielcarek, Nathalie, 1970-...
Nathalie Mielcarek researcher
VIAF ID: 198831548 (Personal)
Permalink: http://viaf.org/viaf/198831548
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Bordetella pertussis from functional genomics to intranasal vaccination | |
Characterization and implication of autophagy pathways in the intracellular degradation of Bordetella pertussis, the Whooping Cough's agent. | |
Développement de Bordetella pertussis comme vecteur vivant vaccinal administrable par voie nasale : application au modèle de la schistosomiase | |
Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. | |
Effect of maternal immune status on responsiveness of bacillus calmette-gurin vaccination in mouse neonates. | |
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases | |
Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis | |
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e. | |
The ins and outs of pertussis toxin | |
Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin | |
Intérêt éthique et scientifique des modèles cellulaires dans l’étude de la relation hôte-pathogène : exemple de l’infection à Bordetella pertussis, agent de la coqueluche | |
Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. | |
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection | |
Local transient induction of inflammatory cytokines after intranasal administration of recombinantBordetella pertussis | |
Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. | |
A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection | |
Nasal Administration of Schistosoma mansoni Egg Antigen-Cholera B Subunit Conjugate Suppresses Hepatic Granuloma Formation and Reduces Mortality in S. mansoni-Infected Mice | |
New pertussis vaccination approaches: en route to protect newborns? | |
PERISCOPE: road towards effective control of pertussis | |
Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae | |
A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers | |
Reciprocal interference of maternal and infant immunization in protection against pertussis | |
Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection | |
Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis |